Vect Horus

VECT-HORUS’ mission is to provide innovative delivery technologies that overcome biological barriers primarily the BBB, opening new avenues in the treatment and imaging of central nervous system diseases and cancers. VECT-HORUS combines molecules of interest to peptide-vectors that specifically target receptors involved in receptor mediated transport. This technology can be applied to the transport of small molecules, peptides, oligonucleotides and large molecules such as proteins and antibodies. The Company has already shown the proof of concept of its technology in animal models for a neuropeptide. Other compounds in cancer, imaging, neurodegenerative diseases are being developed. Some of these compounds are developed in collaboration with pharma Cies (e.g. Sanofi, Servier, Advanced Accelerator Applications).